AbbVie Inc.·4

Mar 3, 6:10 PM ET

Reents Scott T 4

4 · AbbVie Inc. · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

AbbVie (ABBV) CFO Scott Reents Surrenders 21,638 Shares for Taxes

What Happened
Scott T. Reents, Chief Financial Officer of AbbVie Inc., disposed of 21,638 shares on Feb 27, 2026 to satisfy tax withholding obligations. The shares were valued at $232.08 each, for a total consideration of approximately $5,021,747. This was a tax-withholding disposition (not an open-market sale), commonly used to cover taxes from option exercises or restricted stock vesting.

Key Details

  • Transaction date and price: Feb 27, 2026 — 21,638 shares at $232.08 each.
  • Transaction code: F — payment of exercise price or tax liability (shares withheld/disposed to cover taxes).
  • Total value surrendered: ~$5,021,747.
  • Shares owned following the reported transaction: not specified in the provided filing excerpt.
  • Filing: Form 4 filed Mar 3, 2026 (filed within the SEC’s two-business-day window; timely).

Context
Code F dispositions typically reflect shares withheld by the company to meet tax obligations after an exercise or vesting event (a cashless/withholding transaction). These transactions are routine and do not necessarily indicate the insider is selling shares into the open market or signaling a change in sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-27
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2026-02-27$232.08/sh21,638$5,021,74738,777 total
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Scott T. Reents|2026-03-03

Documents

1 file
  • 4
    form4-03032026_060305.xmlPrimary